However, compared with VHL mutant ccRCC patients in sub-cluster1, VHL mutant ccRCC patients in sub-cluster2 were with higher stromal scores in TCGA and E-MTAB-1980 datasets (Fig. 1h). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.